Antares Therapeutics

Website

Antares Therapeutics, Inc.

3 Investors
Pharmaceutical Drug Delivery
BOSTON, MA

Antares Therapeutics, Inc. is a leading specialty pharmaceutical company focused on the creation and commercialization of innovative drug delivery technologies. With a mission to enhance patient experiences associated with injectable medications, the company develops solutions that significantly improve comfort and convenience for individuals requiring regular treatment.

Products & Team

XYOSTED®

Auto-InjectorSeed

XYOSTED® is an auto-injector specifically designed for testosterone replacement therapy. It enables patients to self-administer their medication efficiently and comfortably, overcoming the common barriers associated with traditional injection methods.

Value Proposition

XYOSTED® significantly reduces the anxiety and discomfort associated with traditional needles, thereby improving patient adherence to their hormone therapy regimen.

Pain Points

Patients experience anxiety and discomfort related to needles, non-compliance due to injection difficulties, and the need for frequent medication administration.

User-friendly auto-injection systemDesigned for at-home useEnhances patient comfort and compliance

Andrew Fedder

Company Signatory
General Counselat Antares Therapeutics, Inc.
Joined Antares Therapeutics, Inc.
March 2025
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
BOSTON, MA
Primary headquarters

Funding History

Total Raised:
$40.0M
E

Debt Financing, Option to Acquire Offering

Closed
March 2025
$40.0M
Raised
Progress
100%
Raised
$40.0M
Target
$40.0M
#000205904325000001

Company

  • About Us

Popular Companies

  • Biophoundry
  • Ensemble Labs

© 2026 TinyTechFund. All rights reserved.